Leyla Yavuz Saricay, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corneal Dystrophies, Hereditary | 3 | 2023 | 64 | 1.740 |
Why?
|
| Trigeminal Nerve Diseases | 3 | 2022 | 49 | 1.690 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2024 | 51 | 0.900 |
Why?
|
| Aicardi Syndrome | 1 | 2023 | 16 | 0.850 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 2022 | 56 | 0.830 |
Why?
|
| Refractive Errors | 1 | 2024 | 147 | 0.820 |
Why?
|
| Keratitis | 2 | 2022 | 241 | 0.810 |
Why?
|
| Strabismus | 1 | 2024 | 317 | 0.670 |
Why?
|
| Retinitis Pigmentosa | 1 | 2023 | 397 | 0.650 |
Why?
|
| Spasms, Infantile | 1 | 2023 | 298 | 0.650 |
Why?
|
| Uveitis | 1 | 2022 | 395 | 0.640 |
Why?
|
| Neuralgia | 1 | 2021 | 615 | 0.480 |
Why?
|
| Visual Acuity | 1 | 2024 | 2672 | 0.470 |
Why?
|
| Leukemia | 1 | 2022 | 1522 | 0.470 |
Why?
|
| Glaucoma | 1 | 2023 | 1185 | 0.420 |
Why?
|
| Recurrence | 1 | 2024 | 8466 | 0.380 |
Why?
|
| Nerve Growth Factor | 2 | 2023 | 158 | 0.240 |
Why?
|
| Astigmatism | 1 | 2024 | 68 | 0.230 |
Why?
|
| Lichen Planus | 1 | 2024 | 70 | 0.220 |
Why?
|
| Refraction, Ocular | 1 | 2024 | 184 | 0.210 |
Why?
|
| Optic Atrophy | 1 | 2023 | 79 | 0.210 |
Why?
|
| Diplopia | 1 | 2024 | 214 | 0.210 |
Why?
|
| Vigabatrin | 1 | 2023 | 88 | 0.200 |
Why?
|
| Eye Pain | 1 | 2021 | 46 | 0.190 |
Why?
|
| Child Abuse, Sexual | 1 | 2024 | 403 | 0.190 |
Why?
|
| Intracranial Hypertension | 1 | 2023 | 193 | 0.190 |
Why?
|
| Administration, Topical | 1 | 2023 | 704 | 0.180 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2024 | 354 | 0.180 |
Why?
|
| Vitreous Body | 1 | 2022 | 399 | 0.180 |
Why?
|
| Oculomotor Muscles | 1 | 2024 | 406 | 0.170 |
Why?
|
| Nerve Growth Factors | 1 | 2022 | 564 | 0.170 |
Why?
|
| Craniosynostoses | 1 | 2023 | 412 | 0.160 |
Why?
|
| Epithelium, Corneal | 1 | 2022 | 253 | 0.160 |
Why?
|
| Cornea | 2 | 2022 | 1333 | 0.140 |
Why?
|
| Child | 6 | 2024 | 80158 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2022 | 2571 | 0.140 |
Why?
|
| Corneal Diseases | 1 | 2022 | 542 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 1971 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2024 | 2161 | 0.120 |
Why?
|
| Anticonvulsants | 1 | 2023 | 1906 | 0.110 |
Why?
|
| Biological Products | 1 | 2022 | 914 | 0.100 |
Why?
|
| Retina | 1 | 2023 | 2659 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2024 | 42232 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 1875 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3060 | 0.090 |
Why?
|
| Humans | 10 | 2024 | 761596 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26129 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2024 | 80647 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 221210 | 0.060 |
Why?
|
| Female | 5 | 2024 | 392705 | 0.050 |
Why?
|
| Adolescent | 3 | 2024 | 88326 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 2022 | 313 | 0.040 |
Why?
|
| Male | 4 | 2024 | 360846 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 58984 | 0.040 |
Why?
|
| Young Adult | 1 | 2024 | 59260 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2023 | 811 | 0.040 |
Why?
|
| Walking | 1 | 2024 | 1198 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2024 | 1088 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 2917 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 169310 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 220921 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 36426 | 0.010 |
Why?
|